New York, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cryptococcosis Treatment Market Research Report by Treatment, by Distribution - Global Forecast to ...
Ultimately, the goal is to find ways to stop deadly disease caused by Cryptococcus neoformans from developing in humans and animals. But until that time, finding new and better ways to treat already ...
A lab has completed a six-year study to examine the virulence of 38 clinical isolates from various strains of Cryptococcus. Ultimately, the goal is to find ways to stop deadly disease caused by ...
A group of international mycology experts led by Professor Dr. Oliver A. Cornely at the University of Cologne has jointly drafted a guideline for the diagnosis and treatment of cryptococcosis, which ...
New York, April 14, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cryptococcosis Treatment Market Research Report by Treatment , by ...
DUBLIN--(BUSINESS WIRE)--The "Cryptococcosis Treatment Market Research Report by Treatment (Amphotericin B, Fluconazole, and Flucytosine), by Distribution (Hospital Pharmacies, Mail Order Pharmacies, ...
Researchers devised a way to deliver drugs across the brain’s protective barrier using nanoparticles mimicking a fungal infection strategy.
Cryptococcus is a yeast, which is a kind of fungus. This yeast infects those with poor immunity, like people with HIV. Cryptococcus has a liking for the nervous system, and it often causes meningitis ...
Ultimately, the goal is to find ways to stop deadly disease caused by Cryptococcus neoformans from developing in humans and animals. But until that time, finding new and better ways to treat already ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results